32 results on '"Heddle, Robert J."'
Search Results
2. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
3. The development of Jack Jumper ant venom immunotherapy: our 25 years' experience
4. Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy
5. Beware of allergic reactions to stings and bites.
6. Myrmecia pilosula (Jack Jumper) ant venom: Validation of a procedure to standardise an allergy vaccine
7. Immediate-type hypersensitivity drug reactions
8. Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial
9. Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom
10. Ultrarush versus semirush initiation of insect venom immunotherapy: A randomized controlled trial
11. Efficacy of ant venom immunotherapy and whole body extracts
12. Can serum mast cell tryptase help diagnose anaphylaxis?
13. Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania
14. Fatal anaphylaxis following jack jumper ant sting in southern Tasmania
15. Anaphylaxis to stings and bites
16. Optimizing the management of allergic rhinitis: An Australian perspective
17. Non-conventional approaches to allergy testing: Reconciling patient autonomy with medical practitioners' concerns
18. Causes of ant sting anaphylaxis in Australia: the Australian Ant Venom Allergy Study
19. Increased Intestinal Permeability in Atopic Eczema
20. Hepatic encephalopathy precipitated by sodium valproate therapy
21. Prevention of anaphylaxis with ant venom immunotherapy
22. Skinprick‐test sensitivity to olive pollen: In reply
23. Skinprick test sensitivity to olive pollen
24. IgE+ cells in the peripheral blood of atopic, nonatopic, and bee venom–hypersensitive individuals exhibit the phenotype of highly differentiated B cells
25. Vega testing in the diagnosis of allergic conditions
26. Urticaria and angio‐oedema
27. Extrinsic factors in atopic eczema
28. Bee‐sting mortality in Australia
29. Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
30. Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy
31. Immediate-type hypersensitivity drug reactions
32. Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.